tiprankstipranks
Trending News
More News >
Stayble Therapeutics AB (SE:STABL)
FRANKFURT:STABL
Sweden Market

Stayble Therapeutics AB (STABL) Financial Statements

Compare
0 Followers

Stayble Therapeutics AB Financial Overview

Stayble Therapeutics AB's market cap is currently kr14.61M. The company's EPS TTM is kr-0.023; its P/E ratio is -1.33; Stayble Therapeutics AB is scheduled to report earnings on November 19, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr -148.21Kkr 0.00kr 0.00kr 0.00kr 0.00
Operating Incomekr -12.79Mkr -23.95Mkr -24.80Mkr -12.14Mkr -14.93M
EBITDAkr -12.22Mkr 309.41Kkr -24.50Mkr -12.03Mkr -15.09M
Net Incomekr -12.42Mkr -23.74Mkr -24.53Mkr -12.04Mkr -15.49M
Balance Sheet
Cash & Short-Term Investmentskr 2.19Mkr 14.08Mkr 12.85Mkr 37.47Mkr 10.87M
Total Assetskr 9.26Mkr 21.70Mkr 19.15Mkr 43.64Mkr 18.00M
Total Debtkr 850.00Kkr 850.00Kkr 850.00Kkr 850.00Kkr 850.00K
Net Debtkr -1.34Mkr -13.23Mkr -12.00Mkr -36.62Mkr -10.02M
Total Liabilitieskr 2.38Mkr 5.19Mkr 3.87Mkr 3.83Mkr 2.45M
Stockholders' Equitykr 6.87Mkr 16.51Mkr 15.28Mkr 39.81Mkr 15.55M
Cash Flow
Free Cash Flowkr -14.67Mkr -23.54Mkr -24.89Mkr -9.63Mkr -23.98M
Operating Cash Flowkr -14.67Mkr -23.54Mkr -24.89Mkr -9.63Mkr -23.98M
Investing Cash Flowkr 0.00kr 0.00kr 1.00Kkr -1.00Kkr 0.00
Financing Cash Flowkr 2.78Mkr 24.96Mkr 1.00Kkr 36.15Mkr 31.19M
Currency in SEK

Stayble Therapeutics AB Earnings and Revenue History

Stayble Therapeutics AB Debt to Assets

Stayble Therapeutics AB Cash Flow

Stayble Therapeutics AB Forecast EPS vs Actual EPS